CorMedix Inc. (NASDAQ:CRMD) Q3 2023 Earnings Call Transcript November 14, 2023 CorMedix Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.21. Operator: Good afternoon, and welcome to CorMedix Third Quarter 2023 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I would like to turn the conference over to […]
Related Keywords
Joseph Todisco , Matt David , Pediatric Research Equity , Pharmaceuticals For Children , Pediatric Research Equity Act , Best Pharmaceuticals , Cormedix , Joe Todisco , Fda , Reimbursement , Phoebe Mounts , Product Candidates ,
comparemela.com © 2020. All Rights Reserved.